30
Z.-H. Li et al. / Applied Catalysis A: General 425–426 (2012) 28–34
obvious loss in activity or in enantioselectivity. As the catalyst was
immobilized by ionic tag, it could be recycled in the absence of addi-
tional ionic liquids. The recycling procedure was simple and easy
to operate.
N2 atmosphere, the mixture was stirred for 8 h. The reaction
mixture was subsequently quenched by the addition of brine
(10 mL). The organic layer was washed with water (3× 10 mL)
and dried over Na2SO4, the solvent was removed under vacuum
to afford the crude product, which was purified by column chro-
matography (SiO2, EtOAc/PE 1/1 to EtOAc) to afford 5; yield:
0.430 g (55%). Mp: 42–45 ◦C. [␣]D20 = 131.8 (c = 0.28, CHCl3). 1H
NMR (500 MHz, CDCl3): ı = 7.73–7.71 (d, J = 8.0 Hz, 4H, OTs-ph-
CH), 7.50–7.48 (m, 2H, Ph-H), 7.37 (d, J = 8.0 Hz, 4H, OTs-ph-CH),
7.26–7.24 (m, 6H, Ph-H), 5.53–5.52 (d, J = 8.0 Hz, 2H, oxazoline-
CHN), 5.24–5.22 (dd, J = 7.0 Hz and 6.5 Hz, 2H, oxazoline-CHO),
3.75–3.71 (m, 4H, CH2CH2OTs), 3.32–3.24 (dd, J = 7.0 Hz and 18.0 Hz,
2H, CH(CH)CH), 2.90 (d, J = 18.0 Hz, 2H, CH(CH)CH), 2.49 (s, 6H, OTs-
CH3), 1.82–1.74 (m, 4H, CCH2CH2), 1.44–1.27 (m, 4H, CH2CH2CH2),
2. Experimental
2.1. Synthesis of new ligands
2.1.1. Synthesis of
(3aR,8aS)-2-(1,9-bis(tert-butyldimethylsilyloxy)-5-((3aR,8aS)-
8,8a-dihydro-3aH-indeno[1,2-d]
oxazol-2-yl)nonan-5-yl)-8,8a-dihydro-3aH-indeno[1,2-d]
oxazole 3
0.88 (m, 4H, CH2CH2CH2). MS (ESI): m:z = 783.2 M+1+
A solution of 1 (1.975 g, 6.00 mmol) in 90 mL of dry THF was
cooled to −50 ◦C under a N2 atmosphere. A solution of MeLi
(8.30 mL, 1.6 M in Et2O, 13.0 mmol) was added to the solution
drop wise, the resulting mixture was stirred at −50 ◦C for 1 h,
and then 2 (4.710 g, 15.0 mmol) was added slowly to the mixture.
After the addition was complete, the solution was left to warm to
room temperature and stirred for an additional 3 days. The reac-
tion mixture was quenched by the addition of water (60 mL) and
extracted with EtOAc (3× 30 mL). The organic fractions were com-
bined, washed with brine (1× 40 mL) and H2O (1× 40 mL), and dried
over Na2SO4. The solvent was removed under vacuum to afford a
thick, dark, oily residue, which was purified by column chromatog-
raphy (SiO2, PE/EtOAc, 10/1) to afford 3 as a pale yellow solid; yield:
3.360 g (80%). Mp 76–78 ◦C. [␣]D20 = 186.6 (c = 0.12, CHCl3). 1H NMR
(500 MHz, CDCl3): ı = 7.51 (m, 2H, Ph-H), 7.28–7.43 (m, 6H, Ph-H),
5.54 (d, J = 8.0 Hz, 2H, oxazoline-CHN), 5.22–5.20 (dd, J = 8.0 Hz and
7.0 Hz, 2H, oxazoline-CHO), 3.42–3.34 (m, 4H, CH2CH2O), 3.30–3.25
(dd, J = 7.0 Hz and 17.5 Hz, 2H, CH(CH)CH), 2.90–2.87 (d, J = 17.5 Hz,
2H, CH(CH)CH), 1.94–1.86 (m, 4H, CCH2CH2), 1.41–4.33 (m, 4H,
CH2CH2CH2), 1.05–0.82 (m, 4H, CH2CH2CH2), 0.90(s, 18H, tBu) 0.01
(s, 12H, OSi(CH3)2). 13C NMR (125 MHz, CDCl3): 167.8, 141.9, 139.5,
128.3, 127.3, 125.6, 124.9, 82.8, 76.3, 62.9, 45.6, 39.5, 32.9, 31.5,
26.0, 19.7, 18.2, −5.2. MS (ESI): m:z = 703.4 M+1+.
.
2.1.4. Synthesis of
1,1ꢀ-{5,5-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]
oxazol-2-yl)nonane-1,9} bis-(1-methyl-pyrrolidinium) diOTs 6
5
(0.206 g, 0.263 mmol) and 1-methylpyrrolidine (0.09 g,
1.05 mmol) were dissolved in 1 mL of CH3CN, and the solution
was stirred for 24 h under N2 atmosphere. CH3CN was removed
under high vacuum. The residue was washed with Et2O (3×
10 mL) until it changed to a white solid; yield: 0.075 g (30%). Mp:
181–184 ◦C. [␣]D20 = 111.3 (c = 0.18, CH2Cl2). 1H NMR (400 MHz,
CDCl3): ı = 7.71–7.69 (d, J = 8.0 Hz, 4H, OTs-ph-CH) 7.46 (m, 2H,
Ph-H), 7.25–7.21 (m, 6H, Ph-H), 7.12 (d, J = 8.0 Hz, 4H, OTs-ph-
CH), 5.50–5.49 (d, J = 7.5 Hz, 2H, oxazoline-CHN), 5.22–5.20 (dd,
J = 7.5 Hz and 7.0 Hz, 2H, oxazoline-CHO), 3.42 (m, 4H, CH2CH2N),
3.34–3.32 (dd, J = 7.0 Hz and 18.0 Hz, 2H, CH(CH)CH), 2.92–2.90
(br, 8H, pyrrolidine-H), 2.87–2.83 (d, J = 18.0 Hz, 2H, CH(CH)CH),
2.45 (s, 6H, OTs-CH3), 2.31 (s, 6H, pyrrolidine-CH3) 2.02 (br, 8H,
pyrrolidine-H), 1.91–1.85 (m, 4H, CCH2CH2), 1.61–1.52 (m, 4H,
CH2CH2CH2), 1.04–1.01 (m, 4H, CH2CH2CH2). 13C NMR (100 MHz,
CDCl3): 167.2, 143.9, 141.8, 139.5, 139.2, 128.6, 128.2, 127.3, 125.8,
125.0, 83.0, 75.9, 64.0, 48.1, 45.1, 39.3, 30.9, 23.7, 21.4, 20.2. HRMS
(ESI): calc. for C39H54N4O22+: 305.2117; found: 305.2111.
2.1.5. Synthesis of
2.1.2. Synthesis of
5,5-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]
1,1ꢀ-{5,5-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]
oxazol-2-yl)nonane-1,9} bis-(1,2-dimethyl-1H-imidazole) diOTs 7
5 (0.252 g, 0.32 mmol) and 1,2-dimethyl-1H-imidazole (0.193 g,
2.0 mmol) were dissolved in 2 mL of toluene, and the solution
was heated to 70 ◦C for 24 h under N2 atmosphere. Toluene
was removed under high vacuum. The residue was washed with
Et2O (3× 10 mL) until it changed to a light-yellow solid; yield:
0.156 g (51%). Mp: 77–79 ◦C. [␣]D20 = 38.5 (c = 0.26, CH2Cl2). 1H NMR
(500 MHz, CDCl3): ı = 7.67–7.65 (d, J = 8.0 Hz, 4H, OTs-ph-CH), 7.46
(m, 2H, Ph-H), 7.38 (s, 2H, imidazole-CH), 7.28 (s, 2H, imidazole-CH),
7.21 (d, J = 8.0 Hz, 4H, OTs-ph-CH), 7.09 (m, 6H, Ph-H), 5.51–5.50 (d,
J = 8.0 Hz, 2H, oxazoline-CHN), 5.24–5.21 (dd, J = 7.0 Hz and 7.0 Hz,
2H, oxazoline-CHO), 3.82–3.70 (m, 10H, CH2CH2mim + imidazole-
CH3), 3.31–3.26 (dd, J = 7.0 Hz and 18.5 Hz, 2H, CH(CH)CH), 2.92
(d, J = 18.5 Hz, 2H, CH(CH)CH), 2.59 (s, 6H, imidazole-CH3), 2.49
(s, 6H, OTs-CH3), 1.85–1.79 (m, 4H, CCH2CH2), 1.52–1.22 (m, 4H,
CH2CH2CH2), 0.90–0.75 (m, 4H, CH2CH2CH2). 13C NMR (125 MHz,
CDCl3): 167.3, 143.7, 141.9, 139.3,139.1, 128.6, 128.4, 125.4, 125.1,
122.7, 120.4, 119.0, 83.2, 76.0, 48.1, 45.1, 39.4, 35.5, 34.1, 32.1, 29.4,
21.2, 20.3, 10.7, 9.8. HRMS (ESI): calc. for C39H48N6O22+: 316.1914;
found: 316.1918.
oxazol-2-yl)nonane-1,9-diol 4
A solution of 3 (0.50 g, 0.70 mmol) in 4 mL of dry THF was
cooled to 0 ◦C under N2 atmosphere. TBAF (0.371 g) in 3 mL of THF
was added to the solution drop wise, and the resulting mixture
was warmed to room temperature and stirred for 8 h. The reac-
tion mixture was subsequently quenched by the addition of water
(10 mL), washed with EtOAc (10 mL) and then with brine (10 mL),
extracted with EtOAc (2× 5 mL). The organic fractions were dried
over Na2SO4, and the solvent was removed under vacuum to afford
the crude product, which was purified by column chromatography
(SiO2, EtOAc to EtOAc/EtOH, 1:1) to afford 4 as a yellow solid; yield:
0.236 g (71%). Mp: 120–121 ◦C. [␣]D20 = 261.9 (c = 0.40, CH2Cl2). 1
H
NMR (500 MHz, CDCl3): ı = 7.50–7.48 (m, 2H, Ph-H), 7.27 (m, 6H,
Ph-H), 5.56–5.54 (d, J = 7.5 Hz, 2H, oxazoline-CHN), 5.29–5.26 (dd,
J = 7.5 Hz and 7.0 Hz, 2H, oxazoline-CHO), 3.48 (m, 4H, CH2CH2O),
3.305–3.31 (dd, J = 7.5 Hz and 18.0 Hz, 2H, CH(CH)CH), 2.90–2.87 (d,
J = 18.0 Hz, 2H, CH(CH)CH), 1.89–1.83 (m, 4H, CCH2CH2), 1.46–1.27
(m, 4H, CH2CH2CH2), 1.15–0.95 (m, 4H, CH2CH2CH2). 13C NMR
(125 MHz, CDCl3): 168.1, 141.7, 139.4, 128.4, 127.5, 125.6, 125.0,
83.1, 75.8, 61.5, 45.7, 39.4, 31.9, 19.5. MS (ESI): m:z = 475.2 M+1+
.
2.1.6. Synthesis of
2.1.3. Synthesis of
5,5-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]
oxazol-2-yl)nonane-1,9-ditosylate 5
To a solution of 4 (0.474 g, 1.0 mmol) in 5 mL of DCM, TsCl
(0.760 g, 4.0 mmol) and Et3N (0.404 g, 4.0 mmol) were added under
1,1ꢀ-{5,5-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]
oxazol-2-yl)nonane-1,9} bis-(1,2-dimethyl-1H-imidazole) diPF6
8
7 (0.125 g, 0.13 mmol) was dissolved in 2 mL of H2O, KPF6
(0.048 g, 0.26 mmol) was added to the solution and stirred for
6 h at room temperature. The resultant white solid was filtered